CDNA
CareDx
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
CDNA Profile
Caredx, Inc.
A leading precision medicine solutions company that focused on developing healthcare solutions for transplant patients and caregivers
Healthcare Equipment and Supplies
12/21/1998
07/17/2014
NASDAQ Stock Exchange
644
12-31
Common stock
8000 Marina Boulevard, Brisbane, California 94005
--
CareDx, Inc., was incorporated in Delaware on December 21, 1998. The company is a commercial stage company that develops decision markets and provides heart transplants to patients to help clinicians diagnose, monitor solutions and personalize treatments. CareDx's first commercialized test protocol, AlloMap Molecular Test Heart Transplant, or AlloMap Blood-Based Test, is used to monitor acute cellular rejection after heart transplantation.